PRELUDE THERAPEUTICS INC shareholders Q1 2023

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

PRELUDE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ROYAL BANK OF CANADA 5,258$30,0000.00%
D. E. Shaw & Co., Inc. 47,249$269,3190.00%
VANGUARD GROUP INC 916,014$5,221,2800.00%
BESSEMER GROUP INC 89$10.00%
TD ASSET MANAGEMENT INC 28,440$162,1080.00%
JANE STREET GROUP, LLC 64,470$367,4790.00%
Cubist Systematic Strategies, LLC 8,778$50,0350.00%
Point72 Asset Management, L.P. 1,222$6,9650.00%
UBS Group AG 980$5,5860.00%
Man Group plc 22,663$129,1790.00%
TWO SIGMA INVESTMENTS, LP 22,455$127,9940.00%
OSAIC HOLDINGS, INC. 500$2,8500.00%
DIMENSIONAL FUND ADVISORS LP 12,759$72,7260.00%
BANK OF AMERICA CORP /DE/ 28,186$160,6600.00%
WELLS FARGO & COMPANY/MN 178$1,0150.00%
NORTHERN TRUST CORP 21,167$120,6520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists PRELUDE THERAPEUTICS INC's shareholders in Q1 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.